Trial NCT05061654

View at ClinicalTrials.gov 
Org. Study IDs: MRC-02-21-015

Last trial update was posted on 2023-08-14

MeSH Interventions

Ceftolozane Ceftolozane, tazobactam drug combination Tazobactam

MeSH Conditions

Febrile Neutropenia Hematologic Neoplasms Neutropenia

Other Conditions

Hematologic Cancer Neutropenia, Febrile

Stopping Reasons

Administrative constraints

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID